Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / chronic weight management | Covered with prior authorization |
| Cardiovascular risk reduction (SELECT indication) | Covered with prior authorization |
Premera covers Wegovy with prior authorization, but only when your employer elected the weight-loss drug benefit.
Source: Premera Blue Cross Pharmacy Policy 5.01.621, Drugs for Weight Management. Verified June 12, 2026.
Plan type: Commercial and Medicare Advantage.
What it costs once they say yes. With commercial insurance the manufacturer savings card takes Wegovy to as little as $25 a month. Your plan sets the copay before the card applies. What Wegovy costs with your plan.
This varies by plan. Weight-loss drug coverage at Premera is employer-elected, not a default benefit. A significant share of Premera commercial members are not covered for obesity-indication GLP-1s regardless of BMI. The pharmacy benefit manager for most Premera commercial plans is Express Scripts.
Coverage by indication
| BMI threshold | BMI 30 or higher, or BMI 27 or higher with a comorbidity, per the policy 5.01.621 criteria |
| Step therapy | Step therapy through phentermine or orlistat may apply to some plan designs. Six months of documented lifestyle change is required. |
What the prior authorization needs:
- Your employer group must have elected the weight-loss drug benefit, which base plans do not include
- Prior authorization is required on all qualifying plans
- Six months of documented lifestyle intervention
- Updated quantity limits took effect January 1, 2026
Policy 5.01.621. Source: Premera Blue Cross Pharmacy Policy 5.01.621, Drugs for Weight Management. Official payer medical policy PDF (public URL, binary; policy number confirmed by search-result title). Verified June 12, 2026. This row is marked lower confidence: the policy document was confirmed at its public URL but served as an unreadable file, so the policy number and framework were cross-checked against secondary sources.
| BMI threshold | BMI 27 or higher with established cardiovascular disease |
| Cardiovascular criteria | Prior cardiovascular disease documented per the SELECT trial enrollment criteria |
| Step therapy | Non-formulary on most plans. The standard formulary exception process is required. |
What the prior authorization needs:
- Formulary exception request through the standard process
- Medicare Advantage pathway: CMS policy allows coverage when a medically accepted indication beyond weight loss exists
Source: Premera Providers, Wegovy Coverage with the New Cardiovascular Indication. Official payer provider news page (HTML, fetched directly). Verified June 12, 2026.
Ozempic, Mounjaro and Rybelsus on Premera Blue Cross plans
Ozempic, Mounjaro and Rybelsus are approved for type 2 diabetes, not weight loss.
Does Premera cover Ozempic?
Yes, with prior approval. Premera pays for Ozempic once your prescriber gets the plan to sign off.
Premera Blue Cross covers Ozempic for type 2 diabetes with prior authorization. The plan requires the patient to be 18 or older, have a type 2 diabetes diagnosis, and have an adequate trial of metformin or a contraindication to it, and it applies a quantity limit at the FDA-approved maximum dose. Premera does not cover Ozempic for weight loss and calls that use investigational. Wegovy is the weight-loss form of semaglutide, and Premera reviews it under a separate weight-management policy that applies only when the employer group elects weight-loss drug coverage.
Commercial non-Medicare. Verified August 27, 2026.
What Premera requires for Ozempic
| Step therapy |
What the prior authorization needs:
- Aged 18 years or older
- Has been diagnosed with type 2 diabetes
- Has had an adequate trial of or a contraindication to metformin
- Will not be used in combination with another GLP-1 or GIP/GLP-1 receptor agonist
- Does not exceed the FDA-approved maximum daily dose (quantity limit applies to all strengths)
Policy 5.01.569. Source: Pharmacotherapy of Type 1 and Type 2 Diabetes Mellitus. payer_policy. Verified August 27, 2026.
Recent change: The July 1, 2026 revision of policy 5.01.569 added an age requirement (18 years or older) to the first-line GLP-1 criteria that include Ozempic.
Does Premera cover Mounjaro?
Yes, with prior approval. Premera pays for Mounjaro once your prescriber gets the plan to sign off.
Premera covers Mounjaro for type 2 diabetes with prior authorization. Under pharmacy policy 5.01.569 (effective July 1, 2026), Mounjaro is medically necessary for adults and children aged 10 or older who have a type 2 diabetes diagnosis and have had an adequate trial of metformin or a contraindication to it, and it cannot be used with another GLP-1 or GIP/GLP-1 drug. Premera does not cover Mounjaro for weight loss and calls that use investigational. Zepbound is the tirzepatide product for weight loss, governed under a separate policy (5.01.621).
Commercial non-Medicare. Verified August 27, 2026.
What Premera requires for Mounjaro
| Step therapy |
What the prior authorization needs:
- Aged 10 years or older
- Documented type 2 diabetes diagnosis
- Adequate trial of, or contraindication to, metformin
- Not used in combination with another GLP-1 or GIP/GLP-1 receptor agonist
- Dose does not exceed the FDA-labeled maximum daily dose
Policy 5.01.569. Source: Pharmacotherapy of Type 1 and Type 2 Diabetes Mellitus (Policy 5.01.569). payer_policy. Verified August 27, 2026.
Recent change: Policy 5.01.569 was last revised June 22, 2026 and took effect July 1, 2026. It sets a minimum age of 10 for Mounjaro.
Does Premera cover Rybelsus?
Yes, with prior approval. Premera pays for Rybelsus once your prescriber gets the plan to sign off.
Premera Blue Cross covers Rybelsus for type 2 diabetes with prior authorization. Under pharmacy policy 5.01.569 (effective July 1, 2026), Rybelsus is a first-line GLP-1 that is medically necessary for adults aged 18 or older who have a type 2 diabetes diagnosis and have had an adequate trial of metformin or a contraindication to it, and it cannot be used with another GLP-1 or GIP/GLP-1 drug. Rybelsus is FDA-approved for type 2 diabetes only, so Premera does not cover it for weight loss. The weight-loss semaglutide is Wegovy, which Premera reviews under a separate policy (5.01.621) that applies only when the employer group elects weight-management drug coverage.
Commercial non-Medicare. Verified August 28, 2026.
What Premera requires for Rybelsus
| Step therapy |
What the prior authorization needs:
- Aged 18 years or older
- Has been diagnosed with type 2 diabetes
- Has had an adequate trial of or a contraindication to metformin
- Will not be used in combination with another GLP-1 or GIP/GLP-1 receptor agonist
- Does not exceed the FDA-approved maximum daily dose (quantity limit of 30 tablets per 30 days applies to all strengths)
Policy 5.01.569. Source: Pharmacotherapy of Type 1 and Type 2 Diabetes Mellitus. payer_policy. Verified August 28, 2026.
Recent change: Policy 5.01.569 was last revised June 22, 2026 and took effect July 1, 2026. The May 1, 2026 annual review added the minimum age of 18 to the first-line GLP-1 criteria that include Rybelsus, and a January 1, 2026 update added a quantity limit of 30 tablets per 30 days for all Rybelsus strengths.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Start with the Premera Blue Cross prior-authorization letter template, which cites this plan's policy and the diagnosis codes a reviewer looks for. Pick the indication that matches your clinical picture.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If the prior-authorization request is denied, the appeal letter library has templates by denial reason, covering peer-to-peer review, Level 1 and Level 2 internal appeal, and external review.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Premera Blue Cross cover Wegovy?
Yes on some plans. Premera covers Wegovy with prior authorization, but only when your employer elected the weight-loss drug benefit. This reflects the published policy verified June 2026.
What does Premera Blue Cross require to approve Wegovy?
For obesity / chronic weight management: The BMI requirement is BMI 30 or higher, or BMI 27 or higher with a comorbidity, per the policy 5.01.621 criteria. Step therapy through phentermine or orlistat may apply to some plan designs. Six months of documented lifestyle change is required.
Why might Premera Blue Cross deny Wegovy even if I meet the criteria?
Weight-loss drug coverage at Premera is employer-elected, not a default benefit. A significant share of Premera commercial members are not covered for obesity-indication GLP-1s regardless of BMI. The pharmacy benefit manager for most Premera commercial plans is Express Scripts.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
